Evin Bozkur

Evin Bozkur

Auto-generated profile, based on publicly available information

Evin Bozkur

Bakırkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences , Istanbul , Türkiye

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2022 in Annales d'Endocrinologie
Verified
Journal Article
Closed access
HPHamide Piskinpasa
Hamide Piskinpasa
SDSema Ciftci Dogansen
Sema Ciftci Dogansen
DMDuygu Metin
Duygu Metin
NSNuri Alper Sahbaz
Nuri Alper Sahbaz
AEAyşe Esen
Ayşe Esen
İÇİLKAY ÇAKIR
İLKAY ÇAKIR

11 October 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
EBEvin Bozkur
Evin Bozkur
STSeda Turgut
Seda Turgut
NPNaim Pamuk
Naim Pamuk
HPHamide Piskinpasa
Hamide Piskinpasa
DMDuygu Metin
Duygu Metin
SDSema Ciftci Dogansen
Sema Ciftci Dogansen
Objective: To evaluate the effects of the pandemic process on those with an endocrinological disease that will require close follow-up from the last visit before the pandemic. Materials and methods: Patients of 3,903 with thyroid, calcium-bone metabolism, adrenal gland, pituitary diseases, and neuroendocrine tumor (NET) were retrospectively scanned. The remaining 855 (656 females and 199 males) patients with active disease or who still needed multidisciplinary approaches were included. The number of patients who continued the disease-related medical procedures and [...] ABSTRACT Objective: To evaluate the effects of the pandemic process on those with an endocrinological disease that will require close follow-up from the last visit before the pandemic. Materials and methods: Patients of 3,903 with thyroid, calcium-bone metabolism, adrenal gland, pituitary diseases, and neuroendocrine tumor (NET) were retrospectively scanned. The remaining 855 (656 females and 199 males) patients with active disease or who still needed multidisciplinary approaches were included. The number of patients who continued the disease-related medical procedures and

10 November 2020 in International Journal of Diabetes in Developing Countries
Verified
Journal Article
Closed access
PDF file
EBEvin Bozkur
Evin Bozkur
AEAyse Esen
Ayse Esen
OPOzlem Polat
Ozlem Polat
YOYildiz Okuturlar
Yildiz Okuturlar
YAYasemin Sefika Akdeniz
Yasemin Sefika Akdeniz
MMMeral Mert
Meral Mert

19 May 2022 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
STSeda Turgut
Seda Turgut
DADidem Acarer
Didem Acarer
HSHakan Seyit
Hakan Seyit
NPNaim Pamuk
Naim Pamuk
HPHamide Piskinpasa
Hamide Piskinpasa
ICIlkay Cakir
Ilkay Cakir
The aim of the study was to compare the IGF-1 levels, metabolic and clinical parameters among the ultrasonographically classified non-alcoholic fatty liver disease (NAFLD) groups and determine the factors that may predict the NAFLD severity in patients with morbid obesity. This study was conducted on 316 morbidly obese patients (250 F/66 M). The data of patients before and 1st-year after bariatric surgery were recorded. According to the ultrasonographically NAFLD screening, patients with normal hepatic features were classified as Group 1(n=57), with mild and moderate NAFLD were classified as Group 2(n=219), and with severe NAFLD were classified as Group 3(n=40). IGF-1 standard deviation scores (SDSIGF1) were calculated according to age and gender. Parameters that could predict the presence and severity of NAFLD were evaluated. IGF-1 levels were significantly associated with Group 3 than Group 1(p=0.037), and the significance remained between the same groups when IGF-1 levels were standardized as SDSIGF1(p=0.036). Decreased levels of SDSIGF1 explained 5% of severe NAFLD than the normal group (p=0.036). Liver Diameter, FPG, ALT, AST, and GGT were also found as significant predictors for severe NAFLD. There were significant differences between pre-and postop values in all groups (p<0.001). This study showed that IGF-1 might be considered a sgnificant predictor of severe NAFLD in morbidly obese patients. It is crucial in clinical practice to determine predictive factors of NAFLD that could support the diagnosis accompanied by non-invasive imaging methods.

5 December 2025 in medRxiv
Verified
Preprint
Open access
PDF file
Dilek Gogas YavuzDilek Gogas Yavuz
Dilek Gogas Yavuz
CYCeyda Dincer Yazan
Ceyda Dincer Yazan
ZHZeliha Hekimsoy
Zeliha Hekimsoy
KAKadriye Aydin
Kadriye Aydin
NGNaile Gokkaya
Naile Gokkaya
EBEvin Bozkur
Evin Bozkur
Backgound: Suppression of thyroid-stimulating hormone (TSH) can adversely affect bone tissue in individuals with differentiated thyroid cancer (DTC).In a multi-center setting, this study aim to examine vertebral fractures (VF) and bone mineral density (BMD) in DTC patients receiving levothyroxine (LT4) suppression therapy. Methods: Clinical measurements done in the last visit, laboratory and radiologic data extracted from patients files. Serum TSH concentrations were divided into four groups based on the American Thyroid Association’s guidelines for TSH suppression: 0.01 mu/L, 0.01-0.1, 0.1–0.5 mu/L, and >0.5 mu/L. Within the preceding year, the BMD measurements obtained in the lumbar and femoral regions with a DXA scanner were recorded. Lateral spinal X-rays obtained within the previous year were evaluated. Results: The study comprised 990 people with DTC. The DXA showed 545 patients with normal BMD, 82 (8.2%) with osteoporosis, and 363 (36.6%). patients had osteopenia. The osteoporotic group exhibited older age (p = 0.001), lower BMI (p = 0.001), and comparable TSH levels compare to the osteopenia and normal BMD groups. In 476 lateral vertebral x-rays, 200 (42%), 131 (27.5%) were significant or severe VF. The severe TSH suppression group had a greater fracture rate than the moderate, mild, and non-suppressed groups(p=0.013). VF patients were older (p = 0.001) and had lower femur neck and L1-L4 BMD. Disease duration, FT4 level, and femur neck BMD affected fracture risk (p = 0.001, pseudo R2: 0.028). Age, femur neck BMD, L1-L4 BMD, and osteocalcin levels were linked with osteoporosis in a multivariate analysis (p = 0.001, pseudo R2: 0.427). TSH subgroups had similar femur neck (p = 0.61) and L1-L4 BMD (p = 0.89). Conclusion: Findings suggest that DTC patients undergoing TSH suppression have a significant risk of VF. Assessment of VF should be integrated into the routine care of DTC survivors to ensure long-term skeletal safety.

3 March 2026 in Turkish Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
İÇİLKAY ÇAKIR
İLKAY ÇAKIR
AKAlev Kural
Alev Kural
ZCZeynep Ceyhanli
Zeynep Ceyhanli
EBEvin Bozkur
Evin Bozkur
FAFelemez ARSLAN
Felemez ARSLAN
MBMuge Bilge
Muge Bilge
Objectives: Chronic Autoimmune Thyroiditis (AIT) is a prevalent etiology of hypothyroidism and is postulated to affect ovarian reserve (OR). Ovarian reserve in patients with hypothyroidism secondary to total thyroidectomy has not yet been specifically investigated. Anti-Mullerian hormone (AMH) is a verified and well-known biomarker reflecting OR. We aimed to investigate AMH levels in patients with hypothyroidism resulting from AIT or total thyroidectomy, and to assess the impact of both hypothyroidism and thyroid autoimmunity on ovarian reserve. Methods: A cross-sectional study conducted at Bakırköy Dr. Sadi Konuk Education and Research Hospital in Istanbul, Turkey, between June 2022-June 2024. The study cohort comprised 56 euthyroid women with established hypothyroidism (30 cases with AIT and 26 post-total thyroidectomy) and 30 age- and BMI-matched healthy women. Parameters measured included AMH, FSH,LH, estradiol, fT3, fT4, TSH, TPOAbs, and TgAbs. Results: No statistically significant difference was detected in AMH levels when comparing hypothyroid patients (irrespective of etiology) and healthy controls. Furthermore, no correlation was observed between AMH levels and TSH and/or thyroid autoantibodies. Conclusions: Regardless of the underlying etiology, women with hypothyroidism demonstrate comparable AMH concentrations of healthy women. Furthermore, thyroid autoimmunity itself does not appear to exert an additional detrimental effect on AMH.